270
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations

, , , , , , , , , , , , , , , , & show all

References

  • Hebert CJ, Hall C, Odoms LN. Lessons learned and applied: what the 20th century vaccine experience can teach us about vaccines in the 21st century. Hum Vaccin Immunother 2012;8(5):560-8
  • Global Public Health Achievements Team, CDC. Corresponding contributor: ram Koppaka. Ten Great Public Health Achievements – Worldwide, 2001–2010. MMWR 2011;60(24):812-18
  • Nicoll A, Ciancio B, Tsolova S, et al. The scientific basis for offering seasonal influenza immunization to risk groups in Europe. Euro Surveill 2008;13:43
  • CEVAG. Available from: www.cevag.org
  • McGraw-Hill Concise Dictionary of Modern Medicine. The McGraw-Hill Companies; Inc, New York; 2002
  • Sachedina N, Donaldson LJ. Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study. Lancet 2010;376(9755):1846-52
  • Altmann M, Fiebig L, Soyka J, et al. Severe cases of pandemic (H1N1) 2009 in children, Germany. Emerg Infect Dis 2011;17(2):186-92
  • Blumental S, Huisman E, Cornet MC, et al. Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey. BMC Infect Dis 2011;11:313
  • Vaccine European New Integrated collaboration Effort. Vaccine influenza vaccination survey in EU/EEA. Seasonal influenza vaccination survey in EU/EEA, influenza season 2009–10. Available from: http://venice.cineca.org/Final_Seasonal_Influenza_Vaccination_Survey_2010.pdf [Last accessed 23 August 2012]
  • WHO. Vaccines against influenza WHO position paper – Nov 2012. Week Epidemiol Rec 2012;47(87):461-76
  • Davis RL, Rubanowice D, Shinefield HR, et al. Immunization levels among premature and low-birth-weight infants and risk factors for delayed up-to-date immunization status. Centers for Disease Control and Prevention Vaccine Safety Datalink Group. JAMA 1999;282(6):547-53
  • Saari TN. Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 2003;112(1 Pt 1):193-8
  • Esposito S, Fumagalli M, Principi N. Immunogenicity, safety and tolerability of vaccinations in premature infants. Expert Rev Vaccines 2012;11(10):1199-209
  • D’Angio CT. Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability. Paediatr Drugs 2007;9(1):17-32
  • D’Angio CT, Heyne RJ, Duara S, et al. Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants. Pediatr Infect Dis J 2011;30(7):570-4
  • Negrete-Esqueda L, Vargas-Origel A. Response to Bacillus Calmette-Guerin vaccine in full-term and preterm infants. Am J Perinatol 2007;24(3):183-9
  • Pilger D, Nguipdop-Djomo P, Abubakar I, et al. BCG vaccination in England since 2005: a survey of policy and practice. BMJ Open 2012;2:e001303
  • Prevention of disseminated TB by BCG: the role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep 1996;45:1-18
  • Sommer C, Resch B, Simoes EA. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J 2011;5:144-54
  • Huppertz H, Salman N, Giaquinto C. Risk Factors for Severe Rotavirus Gastroenteritis. Pediatr Infect Dis J 2008;27:S11-19
  • Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009;58(RR-2):1-25
  • Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;59(RR-8):1-62
  • Nuorti JP, Whitney CG. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010;59(RR-11):1-18
  • James KM, Peebles RS Jr, Hartert TV. Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol 2012;130(2):343-51
  • Usonis V, Anca I, Andre F, et al. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children. BMC Infect Dis 2010;10:168
  • Mészner Z, Anca I, André F, et al. Rotavirus vaccination in central Europe. J Pediatr Gastroenter Nutritr 2013;56:586-96
  • Alexander PM, Eastaugh L, Royle J, et al. Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease. J Paediatr Child Health 2012;48(5):395-401
  • Armstrong C. AAP Updates Guidelines on Immunoprophylaxis for RSV Infection; 2010. Available from: www.aafp.org/afp/2010/0901/p542.pdf [Last accessed from 29 October 2012]
  • Centers for Disease Control and Prevention (CDC). Influenza-associated pediatric deaths – United States, September 2010-August 2011. MMWR 2011;60(36):1233-8
  • Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005;54(RR-8):1-40
  • Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005;294(17):2188-94
  • Neu AM. Immunizations in children with chronic kidney disease. Pediatr Nephrol 2012;27(8):1257-63
  • Fivush BA, Neu AM. Immunization guidelines for pediatric renal disease. Semin Nephrol 1998;18(3):256-63
  • CDC. Guidelines for Vaccinating Kidney Dialysis Patients and Patients with Chronic Kidney Disease; 2006. Available from: www.cdc.gov/diabetes/pubs/pdf/CKD_vaccination.pdf [Last accessed 26 September 2012]
  • WHO Hepatitis B position paper. Week Epidemiol Rec 2006;40(84):405-20
  • Shepherd JE, Grabenstein JD. Immunizations for high-risk populations. J Am Pharm Assoc (Wash) 2001;41(6):839-49. quiz 923-5
  • CDC Diabetes and Flu: what do you need to know and do. Available from: www.cdc.gov/diabetes/news/flu.htm [Last accessed 24 August 2012]
  • Advisory Committee on Immunization Practices. Recommended adult immunization schedule: united States, 2012. Ann Intern Med 2012;156(3):211-17
  • Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 2011;53(5):413-21
  • Jain S, Chaves SS. Obesity and influenza. Clin Infect Dis 2011;53(5):422-4
  • Kwok R. Vaccines: the real issues in vaccine safety. Nature 2011;473(7348):436-8
  • Klein NP, Aukes L, Lee J, et al. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics 2011;127(5):e1139-46
  • American Academy of Pediatrics. Red Book: 2012 Report of the Committee on Infectious Diseases. Pickering LK, ed. 29th ed. American Academy of Pediatrics, Elk Grove Village, IL; 2012
  • Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993;42(RR-4):1-18
  • Rubin LG, Levin MJ, Ljungman P, et al. 2013;IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host. Clin Infect Dis 2014;58(3):e44-e100
  • Orange JS, Ballow M, Stiehm ER, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol 2012;130:S1-24
  • Abraham RS. Relevance of antibody testing in patients with recurrent infections. J Allergy Clin Immunol 2012;130:558-9. e1-e6
  • Pebody RG, Hippisley-Cox J, Harcourt S, et al. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005. Epidemiol Infect 2008;136(3):360-9
  • Price VE, Dutta S, Blanchette VS, et al. The prevention and treatment of bacterial infections in children with asplenia or hyposplenia: practice considerations at the Hospital for Sick Children, Toronto. Pediatr Blood Cancer 2006;46(5):597-603
  • Castagnola E, Fioredda F. Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes. Eur J Haematol 2003;71(5):319-26
  • Pettigrew HD, Teuber SS, Gershwin ME. Clinical significance of complement deficiencies. Ann NY Acad Sci 2009;1173:108-23
  • Menson EN, Mellado MJ, Bamford A, et al. Guidance on vaccination of HIV-infected children in Europe. HIV Med 2012;13(6):333-6; e1-14
  • Mofenson LM, Brady MT, Danner SP, et al. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009;58(RR-11):1-166
  • Sutcliffe CG, Moss WJ. Do children infected with HIV receiving HAART need to be revaccinated? Lancet Infect Dis 2010;10(9):630-42
  • O’Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009;374(9693):893-902
  • Nunes MC, Madhi SA. Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother 2012;8(2):161-73
  • Genc G, Ozkaya O, Aygun C, et al. Vaccination status of children considered for renal transplants: missed opportunities for vaccine preventable diseases. Exp Clin Transplant 2012;10(4):314-18
  • Abzug MJ. Vaccination in the immunocompromised child: a probe of immune reconstitution. Pediatr Infect Dis J 2009;28(3):233-6
  • Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. Atkinson W, Wolfe S, Hamborsky J, eds. 12th ed., second printing. Public Health Foundation, Washington DC; 2012
  • Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant 2009;44(8):453-558
  • Shetty AK, Winter MA. Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation. Ochsner J 2012;12(3):228-43
  • Patel SR, Ortin M, Cohen BJ, et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis 2007;44(5):635-42
  • Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78
  • Heijstek MW, Ott de Bruin LM, Borrow R, et al. Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism: evidence-based recommendations. Autoimmun Rev 2011;11:112-22
  • Bijl M, Agmon-Levin N, Dayer J-M, et al. Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment. Autoimmun Rev 2012;11:572-6
  • Makris M, Conlon CP, Watson HG. Immunization of patients with bleeding disorders. Haemophilia 2003;9(5):541-6
  • CDC Hepatitis B. The Pink Book. Available from: www.cdc.gov/vaccines/pubs/pinkbook/downloads/hepb.pdf [Last accessed 30 November 2012]
  • Belay ED, Bresee JS, Holman RC, et al. Reye’s syndrome in the United States from 1981 through 1997. N Engl J Med 1999;340(18):1377-82
  • Reefhuis J, Honein MA, Whitney CG, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med 2003;349(5):435-45
  • Rubin LG, Papsin B. Cochlear implants in children: surgical site infections and prevention and treatment of acute otitis media and meningitis. Pediatrics 2010;126(2):381-91
  • Andrew M, Robert H, David S. Optimizing pneumococcal vaccination for paediatric cochlear implant recipients using the cochlear implant pneumococcal vaccination flowchart. Cochlear Implants Int 2012;13(4):193-6
  • Kistner-Griffin E, Brune CW, Davis LK, et al. Parent-of-origin effects of the serotonin transporter gene associated with autism. Am J Med Genet B Neuropsychiatr Genet 2011;156(2):139-44
  • WHO. Summary of WHO position papers – recommended routine immunizations for children. Available from: www.who.int/immunization/policy/Immunization_routine_table2.pdf [Last accessed 23 August 2012]
  • Zavadska D, Anca I, Andre F, et al. Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG). Hum Vaccin Immunother 2013;9:2
  • Casswall TH, Fischler B. Vaccination of the immunocompromised child. Expert Rev Vaccines 2005;4(5):725-38
  • General recommendations on immunization. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2011;60(RR-2):3-61
  • Blanton L, Peacock G, Cox C, et al. Neurologic disorders among pediatric deaths associated with the 2009 pandemic influenza. Pediatrics 2012;130(3):390-6
  • Cox CM, Blanton L, Dhara R, et al. 2009;Pandemic influenza A (H1N1) deaths among children – United States, 2009-2010. Clin Infect Dis 2011;52(Suppl 1):S69-74
  • CDC Vaccine Recommendations of the ACIP. Available from: www.cdc.gov/vaccines/hcp/acip-recs/index.html
  • Terviseamet Health Board. Available from: www.terviseamet.ee/nakkushaigused/vaktsineerimine/immuniseerimiskava-valised-vaktsiinid.html
  • Oek. Available from: www.oek.antsz.hu
  • Likumi. Available from: www.likumi.lv/ [Last accessed January 2013]
  • Asociatia Medicilor de Familie Mures. Available from: www.amfms.ro
  • Ministry of Health. Available from: www.ms.gov.ro
  • Centrul National de Supraveghere si Control al Bolilor Transmisibile. Available from: www.insp.gov.ro/cnscbt
  • Vaccinnet Romania. Available from: www.vaccinnet.ro
  • DSP Cluj. Available from: www.dspcluj.ro
  • Úrad verejného zdravotníctva Slovenskej republiky. Available from: www.uvzsr.sk

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.